» Articles » PMID: 8873704

Relationship Between Glasgow Coma Scale and Functional Outcome

Overview
Date 1996 Sep 1
PMID 8873704
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The Glasgow Coma Scale (GCS) is routinely used in the acute care setting after traumatic brain injury (TBI) to guide decisions in triage, based on its ability to predict morbidity and mortality. Although the GCS has been previously demonstrated to predict mortality, efficacy in prediction of functional outcome has not been established. The purpose of this study was to assess the value of the acute GCS in predicting functional outcome in survivors of TBI. This study used the Multicenter National Institute on Disability and Rehabilitation Research TBI Model Systems database of 501 patients who had received acute medical care and inpatient rehabilitation within a coordinated neurotrauma program for treatment of TBI. Initial and lowest 24 hr GCS scores were correlated with the following outcome measures: the Disability Rating Scale (DRS), Rancho Los Amigos Levels of Cognitive Functioning Scale (LCFS), and cognitive and motor components of the Functional Independence Measure (FIM(SM)-COG and FIM(SM)-M). Outcome data were collected at admission to and discharge from the inpatient TBI rehabilitation unit. Correlation analysis revealed only modest, but statistically significant, relationships between initial and lowest GCS scores and outcome variables. Initial and lowest GCS score comparison with outcome demonstrated the following correlation coefficients: admission DRS, -0.25 and -0.28; discharge DRS, -0.24 and -0.24; admission LCFS, 0.31 and 0.33; discharge LCFS, 0.27 and 0.25; admission FIM-COG, 0.36 and 0.37; discharge FIM-COG, 0.23 and 0.23; admission FIM-M, 0.31 and 0.31; discharge FIM-M, 0.25 and 0.21. The GCS as a single variable may have limited value as a predictor of functional outcome.

Citing Articles

Decompressive craniectomy in subarachnoid hemorrhage compared to other etiologies: An institutional experience of 11 years.

Pesonen E, Lammi A, Qian C, Von Und Zu Fraunberg M, Korhonen T, Tetri S Brain Spine. 2025; 5:104203.

PMID: 40007802 PMC: 11850783. DOI: 10.1016/j.bas.2025.104203.


Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management.

Lipsky R, Witkin J, Shafique H, Smith J, Cerne R, Marini A Front Neurosci. 2024; 18:1446076.

PMID: 39450122 PMC: 11500614. DOI: 10.3389/fnins.2024.1446076.


Factors Influencing Objective and Subjective Prospective Memory Measures in Traumatic Brain Injury.

Potvin M, Tetreault G, Audy J, Roy S, Rouleau I Arch Clin Neuropsychol. 2024; 40(1):112-124.

PMID: 38915139 PMC: 11754729. DOI: 10.1093/arclin/acae048.


Can we predict 1-year functional outcomes and mortality following hip fracture in middle-aged and geriatric patients at time of admission?.

Esper G, Meltzer-Bruhn A, Ganta A, Egol K, Konda S Musculoskelet Surg. 2024; 108(1):99-106.

PMID: 38218747 DOI: 10.1007/s12306-023-00804-y.


miR-211-5p targeting MMP9 regulates the expressions of AQP4 in traumatic brain injury.

Wang M, Yu X, Li B, Gao C, Chen Y, Zhang X Acta Neurol Belg. 2023; 123(4):1321-1329.

PMID: 37020131 DOI: 10.1007/s13760-023-02205-1.